Vascepa is a prescription drug that contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. It is used to lower high triglyceride levels in the blood.

According to a study published in the Journal of Clinical Lipidology, Vascepa has shown to be effective in reducing the risk of cardiovascular events in patients with elevated triglyceride levels. The study found that Vascepa reduced the risk of cardiovascular events by 25% in patients with elevated triglyceride levels who were already receiving statin therapy [2].

Additionally, a recent settlement in a patent dispute between Amarin, the manufacturer of Vascepa, and Hikma Pharmaceuticals, has allowed for the continued production and distribution of Vascepa. This settlement ensures that patients who rely on Vascepa will continue to have access to the medication [3].

However, it is important to note that every patient is unique and may respond differently to medication. Therefore, it is important to consult with a healthcare professional to determine if Vascepa is the right medication for you.

Sources:
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379293/
[3] https://www.managedhealthcareexecutive.com/view/vascepas-benefits-people-diabetes-seen-amid-settlement-patent-dispute